相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer
Michael J. Giffin et al.
CLINICAL CANCER RESEARCH (2021)
Self-assembled small molecule natural product gel for drug delivery: a breakthrough in new application of small molecule natural products
Kangkang Zhi et al.
ACTA PHARMACEUTICA SINICA B (2020)
Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid-related orphan receptor γ agonist AZD0284
Sara Asimus et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate
Abbie S. Ireland et al.
CANCER CELL (2020)
TUBB3 Is Associated with High-Grade Histology, Poor Prognosis, p53 Expression, and Cancer Stem Cell Markers in Clear Cell Renal Cell Carcinoma
Yohei Sekino et al.
ONCOLOGY (2020)
New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts
Sylvie Lantuejoul et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer
Yan Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study
Daniel Morgensztern et al.
CLINICAL CANCER RESEARCH (2019)
Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy
Huiying Han et al.
CANCER CELL (2019)
RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype
Demin Cai et al.
NATURE COMMUNICATIONS (2019)
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Charles M. Rudin et al.
NATURE REVIEWS CANCER (2019)
Crying Time and ROR gamma/FOXP3 Expression in Lactobacillus reuteri DSM17938-Treated Infants with Colic: A Randomized Trial
Francesco Savino et al.
JOURNAL OF PEDIATRICS (2018)
Advanced small cell lung cancer (SCLC): new challenges and new expectations
Nikolaos Tsoukalas et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
Decalin-Containing Tetramic Acids and 4-Hydroxy-2-pyridones with Antimicrobial and Cytotoxic Activity from the Fungus Coniochaeta cephalothecoides Collected in Tibetan Plateau (Medog)
Junjie Han et al.
JOURNAL OF ORGANIC CHEMISTRY (2017)
Unravelling the biology of SCLC: implications for therapy
Joshua K. Sabari et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Therapeutic Potential of Steroidal Alkaloids in Cancer and Other Diseases
Qi-Wei Jiang et al.
MEDICINAL RESEARCH REVIEWS (2016)
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
Andrew G. Nicholson et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
Junjian Wang et al.
NATURE MEDICINE (2016)
Refining the treatment of NSCLC according to histological and molecular subtypes
Anish Thomas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Arthpyrones A-C, Pyridone Alkaloids from a Sponge-Derived Fungus Arthrinium arundinis ZSDS1-F3
Junfeng Wang et al.
ORGANIC LETTERS (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Small Cell Lung Cancer: Where Do We Go From Here?
Lauren Averett Byers et al.
CANCER (2015)
REV-ERB and ROR nuclear receptors as drug targets
Douglas J. Kojetin et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
High expression of class III ∼-tubulin in small cell lung carcinoma
Steven Powell et al.
ONCOLOGY LETTERS (2014)
Natural products: A continuing source of novel drug leads
Gordon M. Cragg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Identification of a Selective RORγ Ligand That Suppresses TH17 Cells and Stimulates T Regulatory Cells
Laura A. Solt et al.
ACS CHEMICAL BIOLOGY (2012)
Management of Small Cell Lung Cancer
Raffaele Califano et al.
DRUGS (2012)
Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data
Antonio Rossi et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
Mark G. Manfredi et al.
CLINICAL CANCER RESEARCH (2011)
Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of RORλt Protein
Tao Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity
Jun R. Huh et al.
NATURE (2011)
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Himisha Beltran et al.
CANCER DISCOVERY (2011)
Natural products for cancer chemotherapy
Arnold L. Demain et al.
MICROBIAL BIOTECHNOLOGY (2011)
Treatment of extensive-stage small cell lung carcinoma: current status and future prospects
I. K. Demedts et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer
N Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin treatment in patients with extended disease small-cell lung cancer
A Schmittel et al.
ANNALS OF ONCOLOGY (2006)
Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and leukemia group B trial 9732
HB Niell et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Influence of sex on toxicity and treatment outcome in small-cell lung cancer
S Singh et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model
R Meuwissen et al.
CANCER CELL (2003)
分享论文
